# Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes

Study · id `cardio:ct-nct01393808` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01393808](<https://clinicaltrials.gov/study/NCT01393808>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01393808

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.

## Technical summary

Registry record NCT01393808. Randomized; quadruple masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2015-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 112 participants (enrolled count; ClinicalTrials.gov record NCT01393808, source copy `cardio:ctgov-nct01393808-2017-03-03`, retrieved 2026-10-26)
- Start date: 2011-09 (registry gives no type) (ClinicalTrials.gov record NCT01393808, source copy `cardio:ctgov-nct01393808-2017-03-03`, retrieved 2026-10-26)
- Primary completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01393808, source copy `cardio:ctgov-nct01393808-2017-03-03`, retrieved 2026-10-26)
- Completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01393808, source copy `cardio:ctgov-nct01393808-2017-03-03`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01393808, source copy `cardio:ctgov-nct01393808-2017-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01393808-2017-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes
- Acronym: PROCEED
- Condition: Type 2 Diabetes
- Intervention (Drug): Paricalcitol
- Intervention (Other): placebo
- Lead sponsor: Mario Negri Institute for Pharmacological Research
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Mario Negri Institute for Pharmacological Research (`cardio:org-mario-negri-institute-for-pharmacological-research`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial (`cardio:pubmed-29104158`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3245867dee71c8ac6dfa9680f1f74cb4d7eafe3bd9739ee315637a6f1e9e4ae4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
